ARCHIVES

IDMC Halts Mekinist-Tafinlar Trial Early Due to OS Benefit; Recommends Crossover

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

Breast Cancer Survivors Who Take Aspirin Have 50% Reduced Risk Of Metastasis

February 26, 2010

Fondaparinux Prevents DVT In Acutely III Medical Patients

January 30, 2004

Five Advocates Named To SWOG Committees; NCI, NASA Sign Nanotechnology Agreement.

April 21, 2000

Also NCI prostate SPOREs plan biospecimen bank.

December 10, 2004

Dingell To Challenge NCI, NSABP Handling Of Fraud, Delays

April 8, 1994

FDA Approves Mylotarg For First Relapse Of Acute Myeloid Leukemia In Patients 60+.

June 2, 2000